相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
Shih-Hao Young et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Antonio Facciorusso et al.
CANCERS (2020)
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira-Silva et al.
NATURE (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu et al.
GUT (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Hiroshi Fukui
DISEASES (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma
Jian Zheng et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Statin Use and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study
Jesper Smit et al.
MAYO CLINIC PROCEEDINGS (2017)
Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection
Yunseon Choi et al.
TUMORI (2017)
Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection
Yoshikuni Kawaguchi et al.
BIOSCIENCE TRENDS (2017)
Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection
Yunseon Choi et al.
TUMORI (2017)
Is There Potential for Repurposing Statins as Novel Antimicrobials?
Emma Hennessy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma
Fumitoshi Hirokawa et al.
SURGICAL ONCOLOGY-OXFORD (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis
Parissa Tabrizian et al.
ANNALS OF SURGERY (2015)
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Lee-Won Chong et al.
BMC GASTROENTEROLOGY (2015)
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
Adeel A. Butt et al.
HEPATOLOGY (2015)
The role of hepatic resection in the treatment of hepatocellular cancer
Sasan Roayaie et al.
HEPATOLOGY (2015)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Improving performance of liver biopsy in fibrosis assessment
Tarik Asselah et al.
JOURNAL OF HEPATOLOGY (2014)
Chemopreventive strategies in hepatocellular carcinoma
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
How Do Statins Work? Changing Paradigms With Implications for Statin Allocation
Michael J. Blaha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Jaw-Ching Wu et al.
JOURNAL OF HEPATOLOGY (2009)
Anti-angiogenic and anti-inflammatory effects of statins:: Relevance to anti-cancer therapy
J Dulak et al.
CURRENT CANCER DRUG TARGETS (2005)
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area
YH Huang et al.
LIVER INTERNATIONAL (2005)
Pharmacologic characteristics of statins
JM McKenney
CLINICAL CARDIOLOGY (2003)
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
MA Shibata et al.
CARCINOGENESIS (2003)
Double-edged role of statins in angiogenesis signaling
C Urbich et al.
CIRCULATION RESEARCH (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
分享论文
